Studies on alginate-chitosan microcapsules and renal arterial embolization in rabbits

Journal of Controlled Release

Volumn 84, Issue 3, 2002, Pages 87-98

  Li, Sha ^a   Wang, Xiang Tao ^a   Zhang, Xiao Bin ^a   Yang, Ren Jie ^b   Zhang, Hong Zhi ^b   Zhu, Lin Zhong ^b   Hou, Xin Pu ^a  

^a PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

^b PEKING UNIVERSITY CANCER HOSPITAL AND INSTITUTE   (China)

Author keywords

Adriamycin hydrochloride; Alginate; Chitosan; Microcapsules; Renal arterial embolization

Indexed keywords

ALGINIC ACID; BUFFER; CHITOSAN; DOXORUBICIN; HYDROCHLORIC ACID; PHOSPHATE; SODIUM CHLORIDE; SULFORHODAMINE B; CHITIN; DRUG CARRIER; DRUG DERIVATIVE; GLUCURONIC ACID; HEXURONIC ACID;

ANGIOGRAPHY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ARTIFICIAL EMBOLISM; ASSAY; CANCER CELL CULTURE; CANCER INHIBITION; CATHETERIZATION; CELL SURVIVAL; CONCENTRATION RESPONSE; CONTROLLED STUDY; DISPERSION; DRUG EFFECT; DRUG RELEASE; EMULSION; ENCAPSULATION; FEMALE; GELATION; HELA CELL; HISTOPATHOLOGY; HUMAN; HUMAN CELL; IN VITRO STUDY; MALE; MICROCAPSULE; NONHUMAN; PARTICLE SIZE; PH; PRIORITY JOURNAL; RABBIT; RENAL ARTERY; STAINING; ANIMAL; CELL CULTURE; CELL DIVISION; CHEMISTRY; DOSE RESPONSE; METHODOLOGY;

ALGINATES; ANIMALS; CAPSULES; CELL DIVISION; CHITIN; CHITOSAN; DOSE-RESPONSE RELATIONSHIP, DRUG; DOXORUBICIN; DRUG CARRIERS; EMBOLIZATION, THERAPEUTIC; FEMALE; GLUCURONIC ACID; HEXURONIC ACIDS; HUMANS; MALE; PARTICLE SIZE; RABBITS; RENAL ARTERY; TUMOR CELLS, CULTURED;

EID: 0037028019     PISSN: 01683659     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-3659(02)00214-6     Document Type: Article

References (30)

1. Gohel M.C., Sheth M.N., Jani G.K., Patel H. Design of chitosan microspheres containing diclofenac sodium. Indian J. Pharm. Sci. 56:1994;210-214.
2. Lim L.Y., Wan L.S.C., Thai P.Y. Chitosan microspheres prepared by emulsification and ionotropic gelation. Drug Dev. Ind. Pharm. 23:1997;981-985.
3. King A., Hellerstrom C., Sandler S., Kulseng B., Andersson A., Skjåk-Braek G. Glucose metabolism in vitro of cultured and transplanted mouse pancreatic islets microencapsulated by means of a high-voltage electrostatic field. Diabetes Care. 22:(Suppl. 2):1999;B121-B126.
4. Yu C., Cunningham M., Rogers C., Dinbergs I.D., Edelman E.R. The biological effects of growth factor-toxin conjugates in models of vascular injury depend on dose, mode of delivery, and animal species. J. Pharm. Sci. 87:1998;1300-1304.
5. Chandy T., Mooradian D.L., Rao G.H.R. Evaluation of modified alginate-chitosan-polyethylene glycol microcapsules for cell encapsulation. Artif. Organs. 23:1999;894-903.
6. Liu L.S., Liu S.Q., Ng S.Y., Froix M., Ohno T., Heller J. Controlled release of interleukin-2 for tumor immunotherapy using alginate/chitosan porous microspheres. J. Controlled Release. 43:1997;65-74.
7. Ribeiro A.J., Neufeld R.J., Arnaud P., Chaumeil J.C. Microencapsulation of lipophilic drugs in chitosan-coated alginate microspheres. Int. J. Pharm. 187:1999;115-123.
8. Alexakis T., Boadi D.K., Quong D., Groboillot A., O'Neill I., Poncelet D., Neufeld R.J. Microencapsulation of DNA within alginate microspheres and crosslinked chitosan membranes for in vivo application. Appl. Biochem. Biotechnol. 50:1995;93-106.
9. Rajaonarivony M., Vauthier C., Gouarraze G., Puisieux F., Couvreur P. Development of a new drug carrier made from alginate. J. Pharm. Sci. 82:1993;912-917.
10. Marshall F.F., White R.I., Kaufman S.L., Barth K.H. Treatment of traumatic renal arteriovenous fistulas detachable silicone balloon embolization. J. Urol. 122:(2):1979;237-239.
11. Zupancic B., Bradic I., Batinica S., Radanovic B., Simunic S., Zupancic V., Popovic L., Belina D. Our 10-year experience with embolized Wilms' tumors. Eur. J. Pediatr. Surg. 5:(2):1995;88-91.
12. Zhong Y.Q., Jiang X.T., Sun Q.R., Zhang G.Q., Wang Y. Studies on CDDP-albumin microspheres for hepatic arterial chemoembolization. Acta Pharmacol. Sin. 30:(7):1995;543-548.
13. Dakhil S., Ensminger W., Cho K., Niederhuber J., Doan K., Wheeler R. Improved regional selectivity of hepatic arterial BCNU with degradable microspheres. Cancer. 50:(4):1982;631-635.
14. Kato T., Sato K., Sasaki R., Kakinuma H., Moriyama M. Targeted cancer chemotherapy with arterial microcapsule chemoembolization: review of 1013 patients. Cancer Chemother. Pharmacol. 37:(4):1996;289-296.
15. Esquisabel A., Hernandez R.M., Igartua M., Gascón A.R., Calvo B., Pedraz J.L. Production of BCG alginate-PLL microcapsules by emulsification/internal gelation. J. Microencapsul. 14:1997;627-638.
16. Hari P.R., Chandy T., Sharma C.P.J. Chitosan/calcium alginate microcapsules for intestinal delivery of nitrofurantoin. J. Microencapsul. 13:1996;319-329.
17. Polk A., Amsden B., De Yao K., Peng T., Goosen M.F.A. Controlled release of albumin from chitosan-alginate microcapsules. J. Pharm. Sci. 83:1994;178-185.
18. Okhamafe A.O., Amsden B., Chu W. Modulation of protein release from chitosan-alginate microcapsules using the pH-sensitive polymer hydroxypropyl methylcellulose acetate succinate. J. Microencapsul. 13:1996;497-508.
19. Huang H., Shu S.C., Shih J.H., Kuo C.J., Chiu I.D. Antimony trichloride induces DNA damage and apoptosis in mammalian cells. Toxicology. 129:1998;113-123.
20. Blishchenko E.Yu., Kalinina O.A., Sazonova O.V., Khaidukov S.V., Egorova N.S., Surovoy A.Yu., Philippova M.M., Vass A.A., Karelin A.A., Ivanov V.T. Endogenous fragment of hemoglobin, neokyotorphin, as cell growth factor. Peptides. 22:2001;1999-2008.
21. Schneider C.C., Gibb R.K., Taylor D.D., Wan T., Gerçel-Taylor Ç. Inhibition of endometrial cancer cell lines by mifepristone (RU 486). J. Soc. Gynecol. Invest. 5:1998;335-338.
22. Wu C.B., Wei S.L., Lu W., Zhao Y.L., Gao W.W. Studies on magnetic responsiveness and renal embolization with magnetic microspheres in dogs. Acta Pharmacol. Sin. 29:1994;311-315.
23. Gunther R., Schubert U., Bohl J., Georgi M., Marberger M. Transcatheter embolization of the kidney with butyl-2-cyanoacrylate: experimental and clinical results. Cardiovasc. Radiol. 1:1978;101-108.
24. Sezer A.D., Akbuǧ J. Release characteristics of chitosan treated alginate beads: II. Sustained release of a low molecular drug from chitosan treated alginate beads. J. Microencapsul. 16:1999;687-696.
25. Sezer A.D., Akbuǧa J. Release characteristics of chitosan treated alginate beads: I. Sustained release of a macromolecular drug from chitosan treated alginate beads. J. Microencapsul. 16:1999;195-203.
26. Wu X.M., Deng Y.H., Li H.Q., Qi L.Y. Release characteristics of Ca-alginate gel beads loading adriamycin. J. Shenyang Pharm. Univ. 15:1998;279-280.
27. He P., Davis S.S., Illum L. In vitro evaluation of the mucoadhesive properties of chitosan microspheres. Int. J. Pharm. 166:1998;75-88.
28. Bernkop-Schnürch A., Krajicek M.E. Mucoadhesive polymers as platforms for peroral peptide delivery and absorption: synthesis and evaluation of different chitosan-EDTA conjugates. J. Controlled Release. 50:1998;215-223.
29. Kotzé A.F., Lueβen H.L., De Leeuw B.J., De Boer B.G., Verhoef J.C., Junginger H.E. Comparison of the effect of different chitosan salts and N-trimethyl chitosan chloride on the permeability of intestinal epithelial cells (Caco-2). J. Controlled Release. 51:1998;35-46.
30. Calvo P., Viloa-Jato J.L., Alonso M.J. Evaluation of cationic polymer-coated nanocapsules as ocular drug carriers. Int. J. Pharm. 153:1997;41-50.